SeaStar Medical Holding Corp Income Statement
ICU|2 years of annual SEC 10-K data (FY2024-FY2025)
Line items include revenue, cost of goods sold, gross profit, operating expenses, interest, taxes, and net income with per-share data across 2 fiscal years. All figures from audited SEC 10-K filings.
SeaStar Medical Holding Corp reported $1M in revenue and $12M in net loss for FY2025. Revenue increased 814.1% from FY2024 to FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -9.99 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Revenue | $1.2M | $135.0K |
| Cost of Revenue | $53.0K | $0 |
| Gross Profit | $1.2M | $135.0K |
| SG&A Expense | $5.8M | $8.9M |
| R&D Expense | $7.5M | $9.1M |
| Operating Income | -$12.2M | -$17.8M |
| Interest Expense | - | $244.0K |
| Income Tax | $3.0K | $3.0K |
| Net Income | -$12.2M | -$24.8M |
| EPS (Basic) | -$66.33 | -$30.26 |
| EPS (Diluted) | - | -$30.26 |
| Shares Outstanding | 650.6K | 2.0M |
| Gross Margin | 95.7% | 100.0% |
| Operating Margin | -986.6% | -13216.3% |
| Profit Margin | -984.6% | -18392.6% |